Sale!

NIPA1 Gene SPG6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NIPA1 Gene SPG6 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NIPA1 gene, which are associated with Spastic Paraplegia 6 (SPG6), a rare genetic disorder. This condition is characterized by progressive weakness and stiffness of the legs, which can lead to difficulty walking and other mobility issues. The test aims to provide definitive genetic evidence for the condition, aiding in accurate diagnosis and management.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the NIPA1 gene that are known to cause SPG6. This precise genetic testing can be crucial for affected individuals and their families for understanding the condition, potential treatments, and genetic counseling.

The cost of the NIPA1 Gene SPG6 Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions and supports planning for the future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NIPA1 Gene SPG6 Genetic Test

Cost: AED 4400.0

Overview

The NIPA1 Gene SPG6 Genetic Test is a diagnostic test offered by DNA Labs UAE. This test is designed to identify genetic mutations or variations in the NIPA1 gene, which is associated with a rare genetic disorder called hereditary spastic paraplegia type 6 (SPG6). SPG6 is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the NIPA1 Gene SPG6 Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with NIPA1 Gene SPG6. This information will help in the interpretation of the test results and provide a better understanding of the inheritance pattern of the disorder.

Test Details

The NIPA1 gene is specifically associated with hereditary spastic paraplegia type 6 (SPG6). Next-Generation Sequencing (NGS) technology is utilized for this genetic test, allowing for the simultaneous analysis of multiple genes. In the case of SPG6, NGS is used to sequence the NIPA1 gene and identify any genetic mutations or variations that may be causing the disorder.

NGS genetic testing for the NIPA1 gene in SPG6 serves multiple purposes. It aids in the diagnosis of the disorder and provides information about the specific genetic variant responsible for the condition. This information is valuable for understanding the inheritance pattern of the disorder and for providing genetic counseling to affected individuals and their families.

It is important to note that genetic testing for SPG6 should only be ordered by a healthcare professional with expertise in genetics. The results of the genetic test should be interpreted alongside a thorough clinical evaluation and family history.

Test Name NIPA1 Gene SPG6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NIPA1 Gene SPG6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NIPA1 Gene SPG6
Test Details

The NIPA1 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 6 (SPG6). This disorder is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking.

NGS (Next-Generation Sequencing) is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of SPG6, NGS can be used to sequence the NIPA1 gene and identify any genetic mutations or variations that may be causing the disorder.

NGS genetic testing for the NIPA1 gene in SPG6 can help with diagnosis, as well as provide information about the specific genetic variant causing the condition. This can be useful for understanding the inheritance pattern of the disorder and for providing genetic counseling to affected individuals and their families.

It is important to note that genetic testing for SPG6 is typically only ordered by a healthcare professional with expertise in genetics. The results of the genetic test should be interpreted in conjunction with a thorough clinical evaluation and family history.